Department of Medicine
Dr. Edward H. Cheng

Dr. Edward H. Cheng
Associate Professor of Clinical Medicine
M.D., New York University School of Medicine, 1980

EDUCATION AND TRAINING

  • B.S. Biochemistry, SUNY Stony Brook, Stony Brook, NY, 1976
  • M.D., New York University School of Medicine, New York, NY, 1980
  • Internship, Internal Medicine, University of California San Diego, 1980-1981
  • Residency, Internal Medicine, University of California San Diego, 1981-1983
  • Fellowship in Gastroenterology, SUNY Stony Brook Affiliated Hospitals, Stony Brook, NY, 1983-1985
  • Associate Investigator, Northport Veterans Affairs Medical Center, Northport, NY 1985-1987

APPOINTMENTS
  • Instructor in Medicine, SUNY, Stony Brook, 1987-89
  • Assistant Professor of Medicine, SUNY, Stony Brook, 1989-99
  • Associate Professor of Clinical Medicine, SUNY, Stony Brook, 1999-
  • Director, GI Fellowship Program, Stony Brook University School of Medicine, Stony Brook, NY, 1995-2008
  • Co-Chair, Medical Center Nutrition Committee, VAMC Northport, 1994-
  • Member, Nutrition Support Committee, VAMC Northport, 1987-

BOARD CERTIFICATION

  • National Board of Medical Examiners, 1981
  • American Board of Internal Medicine, 1983
  • American Board of Internal Medicine, Gastroenterology, 1987

AREAS OF CLINICAL EXPERTISE

  • Endoscopy, Capsule endoscopy, Breath tests, pH Monitoring
  • Immunology in GI disease
  • H. pylori and GI disease
  • Educational Issues in Subspecialty Training

CURRENT RESEARCH INTERESTS

  • New treatments in acid-peptic disease
  • New treatments in inflammatory bowel disease
  • Emerging pathogens in GI disease
  • Educational Issues in GI Fellowship Training

PROFESSINAL AFFILIATIONS
  • Fellow, American College of Physicians, 1992
  • Member, American Gastroenterological Association, 1986

PUBLICATIONS
  1. Lee N, Cheng E, Inouye M. Optical properties of an outer membrane lipoprotein from Escherichia coli.  Biochem. Biophys. Acta 1977; 465:650-656.
  2. Bart R, Porzio N, Kopf A, Vilcek J, Cheng E, Farcet Y. Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.  Cancer Research 1980; 40:614-619.
  3. Senda S, Cheng E, Kawanishi H. Aging-associated changes in murine intestinal immunoglobulin A and M se­cretions.  Scand. J. Immunol. 1988; 27:157-164.
  4. Cheng E, Bermanski P, Silversmith M, Valenstein P, Kawanishi H. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease.  Arch. Int. Med. 1989; 149:1373-1375.
  5. Senda S, Cheng E, Kawanishi H. IgG in murine intestinal secretions. Aging effect and possible physiological role.  Scand. J. Immunol. 1989; 29:41-47.
  6. Cheng E, Brugge W. Filiform polyposis in a patient without history of inflammatory bowel disease.  J. Clin. Gastro. 1989; 11:479-481.
  7. Cheng E, Bermanski P, Silversmith M. Prevalence of Campylobacter pylori.  Arch. Int. Med.1990; 150: 1132-1134.
  8. Merchant A, Cheng E. Delayed splenic rupture after colonoscopy.  Amer. J. Gastro. 1990; 85: 906-907.
  9. Cheng E, Pavelock R. Multiple gastrointestinal tract diverticula.  Gastro. Radiol. 1990; 15: 282-284.
  10. Shaw R, Groene W, Mackow E, Merchant A, Cheng E. The VP4-specific intestinal antibody response to ro­tavirus in a murine model of heterotypic infection.  J. Virology 1991; 65:3052-3059.
  11. Merchant A, Groene W, Cheng E, Shaw R. Murine intestinal antibody response to heterologous rotavirus infec­tion.  J. Clin. Micro. 1991; 29: 1693-1701.
  12. Shaw R, Groene W, Mackow E, Merchant A, Cheng E . Recombinant baculovirus-expressed rotavirus protein (VP4) in an Elispot assay of antiboby secretion  Viral Immunol. 1992; 5:51-59.
  13. Chen J, Compton C, Cheng E, Fromowitz F, Viola M.  c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis.  Gastroenterology 1992; 102:1983-1987.
  14. Schwab K, Cheng E.  Postgastrectomy bezoars secondary to gastric cancer.  J. Clin. Gastro. 1993; 16: 45-47.
  15. Shaw, R, Merchant A, Groene W, and Cheng E.  The persistence of the intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year.  J. Virol, 1993. 31: 188-191.
  16. Schwab K, Cheng E.  Endoscopic removal of a penetrating surgical clip from the esophagus.  Gastro Endoscopy 1993; 39: 860.
  17.   Brummer B, Cheng E.  A simple external retention device for Foley replacement gastrostomy tubes.  J. Clin. Gastro.  1995; 20: 337-338.
  18.   Anderson J, Cheng E, Roeske M, Marchildon P, Peacock J, Shaw R.  Detection of serum antibodies to Helicobacter pylori by an immunochromatographic method. Amer J Gastro 92(7): 1135-9, 1997.
  19. Cheng E, Sheikh A, Khan A, Berrutti L. Rapid regression of esophageal squamous cell papilloma with pump inhibitor therapy. Submitted for publication.
 ABSTRACTS
  1. Senda S, Cheng E, Kawanishi H.  Aging-associated changes in murine intestinal immunoglobulin secretes. Gastroenterology  1986; 90:1626. Presented, American Gastroenterological Association, May 1986, San Francisco, CA.
  2. Cheng E, Kawanishi H.  Age differences in interleukin production by gut-associated lymphoid tissues. Gastroenterology 1986; 90:1371. Presented, American Gastroenterological Association, May 1986, San Francisco, CA.
  3. Senda S, Mitsunaga A, Cheng E, Kawanishi H.  Aging and role of IgG in intestinal secretions. Gastroenterology 1987; 92:1633. Presented, American Gastroenterological Association, May 1987, Chicago, IL.
  4. Cheng E, Kawanishi H.  Aging and soluble IL-2 receptor release by gut-associated lymphoid tissue cells. Gastroenterology 1987; 92:1343.
  5. Cheng E, Bermanski P, Silversmith M, Valenstein P, Kawanishi H.  Incidence of Campylobacter pylori in esophagitis and gastritis. Amer. J. Gastro. 1988; 83:1018. Presented, Long Island Gastroenterological Association, April 1988, Long Island, NY.
  6. Cheng E, Bermanski P, Silversmith M, Valenstein P.  Is there an association of Campylobacter pylori and gas­troesophageal reflux disease? Gastroduodenal Disease and Campylobacter pylori Conference, May 1989, Charlottesville, VA.
  7. Cheng E, Shaw R, Groene W, Merchant A, Crisostomo T.  Production of prolactin-like substances by murine gut-associated lymphoid tissues. Gastroenterology 1990; 98: A441. Presented, American Gastroenterological Association, May 1990, San Antonio, TX.
  8. Merchant A, Groene W, Cheng E, Shaw R.  Intestinal antibody response to rotavirus infection in mice. Gastroenterology 1990; 98: A463. Presented, American Gastroenterological Association, May 1990, San Antonio, TX.
  9. Merchant A, Birk J, Cheng E. Serum cholesterol in patients with and without adenomatous polyps on colonoscopy.  Amer. J. Gastro. 1990; 85: 1281.
  10. Groene W, Merchant A, Cheng E, Mackow E, Shaw R. Viral Protein Specificity of the Intestinal Antibody Response to Heterologous Rotavirus Infection in a Murine Model. Presented, American Society for Virology, Salt Lake City, UT, July 1990.
  11. Groene W, Merchant A, Cheng E, Mackow E, Shaw R. Duration of Intestinal Antibody Response to Heterologous Rotavirus Infection in a Murine Model, and Effects of Cholera Toxin as Mucosal Immune Adjuvant. Presented, Third International Symposium on Double-Stranded RNA Viruses, Kona, Hawaii, December 1990.
  12. Merchant A, Groene W, Cheng E, Shaw R.  Characterization of murine intestinal antibody response to ro­tavirus: persistence and boosting. Gastroenterology 1991; 100: A599. Presented, American Gastroenterological Association, May 1991, New Orleans, LA.
  13. Shaw R, Garcia M, Cheng E, Marchildon P, Peacock J.  Evaluation of FlexSure™ HP, a rapid serological assay for H. pylori detection. Gastroenterology 1995; 108. A217. Presented, American Gastroenterological Association, May 1995, San Diego, CA.
  14. Sorbi D, Khan A, Fasseas P, Polonet D, Chang M, Cheng E. Chronic lymphocytic leukemia: an unusual cause of upper and lower gastrointestinal hemorrhage. American College of Physicians, April 1996, San Francisco, CA.
  15. Anderson J, Dickman K, Cheng E, Hempson S, Schatner M, Shaw R. Rotavirus induced changes in transepithelial resistance in Caco-2 monolayers. Gastroenterology 1996;110: A854.  Presented, American Gastroenterological Association, May 1996, San Francisco, CA.
  16. Cheng E, Ashraf K, Roeske M, Shaw R, Marchildon P, Peacock J. Evaluation of a dried plasma collection device for the detectioon of H. pylori antibodies. Gastroenterology 1997;112. A87.
  17. Ahmad J, Cheng E.  Surgery is more cost-effective for severe gastrooesophageal reflux disease than maintenance therapy.  American College of Physicians Associates Research Poster, 1997.
  18. Ahmad J, Cheng E.  Cost effectiveness analysis of misoprostol and famotidine for non-steroidal anti-inflammatory drug induced gastroduodenal damage.  American College of Physicians Associates Research Poster, 1997.
  19. Cheng E, Ashraf K, Rubenbauer F, Roeske M, Shaw R, Marchildon P, Peacock J. Evaluation of a dried plasma collection device for the detection of H. pylori antibodies. Gastroenterology 1998; 114: A90. Presented, American Gastroenterological Association, May 1998, New Orleans, LA.
  20. Shaw R, Roeske M, Rubenbauer F, Marchildon P, Cheng E, Peacock J. Evaluation of salivary antibody    response to Helicobacter pylori in humans. Gastroenterology 1998; 114: A1083.
  21. Woo G, Cheng E, Rubenbauer F, Peacock J. Changes in H. pylori antibody titers during housestaff training.          Amer. J. Gastro. 1998; 93(9): 1649.
  22. Halai A, Reddy I, Cheng E.  Anticoagulation: Can this be associated with increased detection rate of significant colonic lesions? . 2000
  23. Sethi G, Cheng E. Evaluation of alphafetoprotein and ultrasound as screening tools for hepatocellular carcinoma. 2003
  24. Abraham B, Chadda M, Cheng E. Prevalence of osteoporosis in veteran patients with inflammatory bowel disease. 2006.